Citations

The culmination of the below trials and evidence provides clinical documentation and support for the asterisked claims:

*embrace^{^®} is the only scar treatment proven to prevent scar formation in multiple, Level 1 randomized controlled trials

1. Gurtner GC, et al. “Improving Cutaneous Scar by Controlling the Mechanical Environment: Large Animal and Phase 1 Studies.” Annals of Surgery 254-2 (2011): 217-225.

2. DCD10962 Rev A Data on File #002.

3. IMPROVE, Lim AF, et al. The embrace Device Significantly Decreases Scarring Following Scar Revision Surgery in a Randomized Control Trial. (accepted, anticipated publication in PRS Dec 13).

4. Longaker MT, Rohrich RJ, Greenberg L, et al. A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation. Plast Reconstr Surg. 2014; 134(3):536-546.

5. Monstrey S, Middelkoop E, Vranckx JJ, et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg. 2014;67(8):1017-1025.

6. Young, VL, et. al. Insight into Patient and Clinical Concerns about Scar Appearance: Semiquantative Structured Surveys. Plastic and Reconstructive Surgery, July 2009, 256-265.

This site is owned by Neodyne Biosciences, Inc. (“Neodyne”). Neodyne respects the privacy of visitors to this website. This Privacy Policy is designed to tell you about what information we collect while you visit this Website, how Neodyne uses such information, and how you can limit the use of personally identifiable information that we may collect. Please be sure to read this entire Privacy Policy before using or submitting information to this site.

This site and this policy are intended for use by residents of the United States. Different policies may apply to other websites or information that we get offline.